# 12 — Mineral Balance and Neural Excitability: Could Oxalate Contribute Indirectly?

Series: The Oxalate–Brain Hypothesis
Evidence class: Hypothesis—oxalate psychiatry; differentiated human, animal and mechanistic evidence

Editorial status: Third substantive revision, 17 October 2026. Not independently peer reviewed.

## Abstract
The nervous system is sensitive to ionized calcium and other electrolyte disturbances; oxalate can interact with calcium in some compartments. A rigorous oxalate–psychiatry argument must ask whether oxalate-related disease measurably alters the mineral environment of neurons, rather than assuming that every oxalate molecule removes circulating calcium. This paper proposes a specific mineral-mediated route in appropriately ill or susceptible patients.

## From binding chemistry to neuronal physiology
Intestinal calcium binding reduces soluble oxalate absorption. Calcium oxalate crystallization in urine involves a different physical compartment. Systemic ionized calcium is tightly defended by parathyroid, renal and skeletal regulation. Therefore a patient with high urinary oxalate need not have clinically important hypocalcemia, and ordinary dietary intake cannot be equated with calcium depletion in the synapse. The stronger causal theory is conditional: severe oxalate-associated illness, renal dysfunction, altered acid–base state or another mineral disorder may change neuronal excitability or cognition. Its causal validity depends on documented ionized calcium, magnesium, phosphate, renal function and clinical timing.

A study should separate patients with comparable kidney injury but different oxalate loads and analyze whether neural manifestations align with mineral abnormalities rather than total urine oxalate alone. If electrolyte correction reverses cognitive changes while oxalate remains elevated, the mineral pathway gains support and a direct neural oxalate pathway is weakened. This counterfactual is not a defeat for the thesis; it identifies the proximal cause within a larger causal chain.

## A calcium story with three compartments
Calcium in the intestinal lumen can bind oxalate and reduce absorption. Calcium in urine can combine with oxalate to form kidney stones. Ionized calcium in plasma is regulated by parathyroid hormone, vitamin D and the kidneys, and influences neuromuscular excitability. These processes interact through physiology but are not interchangeable. The body does not allow meal-by-meal fluctuations in intestinal free calcium to translate freely into corresponding changes in brain extracellular calcium.

## What mineral disorders actually do
Marked hypocalcemia can cause paresthesias, tetany, seizures and neuropsychiatric changes. Hypercalcemia, especially in severe parathyroid or malignant disease, may produce fatigue, impaired concentration, mood changes or delirium. Significant magnesium abnormalities likewise affect neuromuscular and cardiac function. These examples establish that mental symptoms can have mineral causes. They do not establish that dietary oxalate regularly provokes these abnormalities. Severe ethylene glycol intoxication and advanced kidney failure are special clinical settings, not representative exposures.

## The role of kidney function
Renal disease can disturb calcium, phosphorus, vitamin D and acid–base homeostasis. That offers a credible indirect path from severe oxalate-related nephropathy to altered neurological function. But the risk depends on the actual extent of renal impairment and mineral derangement, not on a theoretical dietary ratio alone. Symptoms without abnormal systemic physiology require competing explanations rather than an assumed hidden calcium depletion.

## A useful boundary
The compelling hypothesis is that oxalate can change mineral handling in defined intestinal and renal contexts, which may influence systemic physiology if disease becomes sufficiently severe. The unsupported hypothesis is that normal oxalate intake continuously removes calcium from the brain and thereby causes anxiety or psychosis. Any persuasive account would require appropriately timed ionized calcium measurements, kidney assessment, exposure context and a neurologically coherent clinical presentation.

## Neural excitability is exquisitely regulated but not easily perturbed by food chemistry
Action potentials, synaptic release and network oscillation depend on tightly controlled gradients of sodium, potassium, calcium, magnesium and hydrogen ions. Clinically important abnormalities of these gradients can cause confusion, altered behavior, seizures or psychiatric-like presentations. This makes mineral physiology an attractive bridge between oxalate and the brain, because oxalate binds calcium under appropriate chemical conditions. The dangerous inference would be to move from intestinal calcium oxalate formation directly to systemic calcium depletion without measuring the endocrine mechanisms that regulate blood ion concentrations. Most dietary oxalate exposure does not create clinically significant hypocalcemia in otherwise healthy individuals.

The better hypothesis begins with susceptibility. Severe oxalate-associated renal disease may coincide with abnormal calcium and phosphate regulation, vitamin D metabolism, magnesium status or metabolic acidosis. Each of these can affect neuronal function, and each must be measured separately. Fat malabsorption adds another set of variables, including deficiencies unrelated to oxalate itself. A patient with cognitive complaints and an established gastrointestinal disorder therefore presents a genuine multidimensional biochemical problem, not a simple equation between spinach and synaptic calcium.

## A proposed mineral–oxalate susceptibility map
The research question can be divided into three layers. First, does the individual have objective evidence of increased oxalate absorption, production or retention? Second, has mineral homeostasis actually changed? Third, do neurological symptoms vary with the relevant mineral disturbance rather than merely with dietary restriction or renal illness? If the answers are yes, a mineral-mediated link becomes plausible. If calcium, magnesium and acid–base measurements are normal during symptoms, a theory depending on a large circulating mineral abnormality is weakened. That would not rule out every subtle cellular effect, but it would rule out that particular explanation.

This suggests careful attention to ionized calcium rather than relying exclusively on total serum calcium in settings where albumin and acid–base status are changing. It also suggests considering urinary chemistry separately from serum chemistry. A high urinary calcium oxalate supersaturation index is about crystallization risk in a fluid compartment; it is not evidence that a neural circuit is experiencing calcium depletion. The same molecule can behave very differently in urine, plasma, gut lumen and synaptic extracellular fluid.

## The psychiatric endpoint must match the mechanism
If a profound electrolyte disturbance causes delirium, the patient has a medically induced disturbance of brain function; calling it a primary psychiatric disorder obscures the causal pathway. If a patient experiences mild anxiety or impaired concentration while all measured electrolytes are normal, a direct ionic account demands additional evidence. A researcher might consider electrophysiological or cognitive measurements, but must not present them as validated oxalate biomarkers without supporting studies. The distinction between delirium, anxiety, depression and psychosis matters because each phenotype has different diagnostic implications and different likely confounders.

An ethically designed prospective cohort could track oxalate and mineral measurements in people with established renal or intestinal oxalate conditions, alongside structured cognitive symptoms and medication records. Such an approach might reveal a subgroup in whom measured mineral dysregulation mediates a neuropsychiatric burden. It might equally show that oxalate is unrelated to the symptoms once kidney function and general illness severity are taken into account. Both outcomes would be meaningful. The ambitious thesis is that oxalate can contribute to disturbed neural physiology in the right terrain; the rigorous test is to identify precisely what that terrain requires.

## Ionized calcium is not interchangeable with calcium oxalate supersaturation
It is useful to imagine two panels printed side by side. The first includes urinary oxalate, urinary calcium, citrate and volume. The second includes serum ionized calcium, magnesium, phosphate and acid–base measures. A patient may have a very abnormal first panel and a normal second panel. That scenario supports a clinically important kidney-stone mechanism without establishing neuronal ionic disturbance. Another patient with major kidney failure may have abnormalities in both panels, but the causation still needs mapping because mineral changes may be produced by multiple renal mechanisms. A psychiatric theory that ignores the differences between the panels will produce apparent contradictions where the physiology is actually coherent.

The falsifiable ionic proposal is that psychiatric manifestations occur preferentially when a specific systemic mineral disturbance accompanies confirmed oxalate disease. If symptoms are unchanged when that disturbance is corrected, the ionic pathway weakens. If symptoms fluctuate independently of systemic minerals but track plasma oxalate, another direct or indirect pathway should be considered. Either possibility needs prospective measurement rather than retrospective selection of favorable results.

There is also a difference between a direct ionic effect at a synapse and a global metabolic effect from renal failure. A patient can be profoundly cognitively impaired from systemic illness without a measurable drop in serum ionized calcium. Such a case cannot be used as evidence for a calcium-depletion mechanism merely because oxalate is chemically capable of binding calcium. Investigators should resist substituting chemical possibility for an observed physiological state. When a systemic mineral abnormality is present, the next challenge is to determine whether it arises from oxalate-associated disease or another process. A reliable model specifies the pathway and admits when the actual measurements do not follow it.

A future investigation should also examine whether symptoms appear before or after the mineral disturbance. If altered calcium regulation follows severe kidney injury and then cognition deteriorates, an indirect pathway is plausible. If symptoms precede measurable systemic change, a different model is needed. Such time ordering is valuable because an association measured at one visit can fit several incompatible causal explanations. The aim is to discriminate them, not to preserve all of them indefinitely.

## Conclusion
The mineral hypothesis becomes stronger as it becomes narrower. The alleged neural effect must pass through measurable ionic physiology rather than rhetoric about oxalate 'stealing calcium' everywhere in the body.

## Selected readings
- Witting et al., Enteric Hyperoxaluria: https://pmc.ncbi.nlm.nih.gov/articles/PMC8011014/

- Primary Hyperparathyroidism and Psychiatric Sequelae: https://pmc.ncbi.nlm.nih.gov/articles/PMC8549683/